Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
62.79
+0.92 (1.49%)
At close: Aug 13, 2025, 4:00 PM
62.79
0.00 (0.00%)
After-hours: Aug 13, 2025, 7:00 PM EDT
Globus Medical Market Cap
Globus Medical has a market cap or net worth of $8.48 billion as of August 13, 2025. Its market cap has decreased by -12.66% in one year.
Market Cap
8.48B
Enterprise Value
8.37B
1-Year Change
-12.66%
Ranking
Category
Stock Price
$62.79
Market Cap Chart
Since August 3, 2012, Globus Medical's market cap has increased from $1.22B to $8.48B, an increase of 594.99%. That is a compound annual growth rate of 16.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 8.36B | -25.81% |
| Dec 31, 2024 | 11.26B | 53.38% |
| Dec 29, 2023 | 7.34B | -0.98% |
| Dec 30, 2022 | 7.42B | 1.22% |
| Dec 31, 2021 | 7.33B | 13.84% |
| Dec 31, 2020 | 6.44B | 9.95% |
| Dec 31, 2019 | 5.85B | 37.32% |
| Dec 31, 2018 | 4.26B | 7.60% |
| Dec 29, 2017 | 3.96B | 66.61% |
| Dec 30, 2016 | 2.38B | -10.27% |
| Dec 31, 2015 | 2.65B | 17.98% |
| Dec 31, 2014 | 2.25B | 19.34% |
| Dec 31, 2013 | 1.88B | 96.83% |
| Dec 31, 2012 | 956.00M | -21.65% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |